Softwr

Healthcare · head to head

Annalise.ai vs Techcyte

Annalise.ai logo

Annalise.ai

Healthcare

Multi-finding chest X-ray and head CT triage AI with FDA clearance on named findings, not on the whole model

From
On request
Rated
-
Full reviewWebsite
Techcyte logo

Techcyte

Healthcare

AI digital pathology across clinical, veterinary and environmental laboratory disciplines

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Annalise.ai the United States cleared indication covers roughly ten findings for triage and notification, far fewer than the model reports, so a buyer who evaluates the full multi-finding output and then contracts in the United States gets a much narrower cleared use.; Techcyte regulatory status runs the opposite way to what most buyers assume: the products are CE marked and clinically deployed in Europe while several United States offerings including Fusion Parasitology are labelled research use only and not for diagnostic use, so an American laboratory must verify each module individually.
  • They diverge on capability: Annalise.ai covers Annalise Enterprise CXR, Techcyte covers Fusion Parasitology Suite.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Annalise.ai and Techcyte actually diverge.

Attributes where Annalise.ai and Techcyte differ
AttributeAnnalise.aiTechcyte
PlatformsWeb, Cloud, On-premiseWeb

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Annalise.ai

  • Annalise Enterprise CXR
  • Annalise Enterprise CTB
  • Triage and notification
  • Worklist reprioritisation
  • Localisation overlays
  • Confidence output
  • PACS-native deployment
  • On-premise or cloud inference

Only in Techcyte

  • Fusion Parasitology Suite
  • Cervical cytology
  • Haematology
  • Urinalysis
  • Bacteriology and mycology
  • Vetcyte
  • Scanner agnostic ingestion
  • Remote review

What people use each for

The jobs each tool is most often brought in to do.

Annalise.ai

  • An emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnestnot Techcyte
  • A teleradiology provider covering many small hospitals that needs consistent triage before a human readsnot Techcyte
  • A screening programme in Europe where the broader CE marked decision support indication, rather than the narrow United States triage clearance, is what is being deployednot Techcyte
  • A radiology department building an AI governance programme that wants one vendor covering both chest radiograph and head CT rather than contracting two separate algorithm suppliersnot Techcyte

Techcyte

  • A clinical laboratory that cannot recruit technologists for high volume manual parasitology screening and needs AI pre screening with human releasenot Annalise.ai
  • A veterinary reference laboratory processing large volumes of faecal and blood smears that wants Vetcyte to triage the normal casesnot Annalise.ai
  • A European laboratory that can deploy the CE marked products clinically, which is where Techcyte regulatory position is strongestnot Annalise.ai
  • An environmental testing laboratory needing consistent microscopy classification across analysts and sitesnot Annalise.ai

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Annalise.ai

  • The United States cleared indication covers roughly ten findings for triage and notification, far fewer than the model reports, so a buyer who evaluates the full multi-finding output and then contracts in the United States gets a much narrower cleared use.
  • Triage AI reprioritises a worklist but does not change clinical decisions on its own, so departments that do not redesign how urgent studies are picked up see no measurable improvement in time to treatment.
  • Published validation is largely reader study evidence on detection of individual findings; prospective evidence of shorter time to treatment in routine emergency care is thin.
  • The Annalise brand is being migrated under the Harrison.ai name for the critical care offering, which creates ambiguity in multi-year contracts about what product name is actually being supported.
  • A high finding count raises the alert burden, and departments report that low prevalence findings generate false positives that erode radiologist trust unless the alerting thresholds are tuned locally.

Techcyte

  • Regulatory status runs the opposite way to what most buyers assume: the products are CE marked and clinically deployed in Europe while several United States offerings including Fusion Parasitology are labelled research use only and not for diagnostic use, so an American laboratory must verify each module individually.
  • Slide scanning for parasitology, haematology and cytology needs multi plane imaging that a histology scanner may not produce, so a laboratory that already owns a scanner often has to buy new hardware, which becomes the biggest line in the project.
  • Each discipline is licensed separately, so a laboratory wanting parasitology, urinalysis and haematology assembles three modules and three validation studies rather than buying one platform.
  • AI pre screening does not remove the need for a qualified reviewer to release results, so the staffing saving is in review time per slide, not in headcount, and business cases that assume otherwise do not hold.
  • Techcyte covers a very wide set of disciplines, which means depth varies between them, and the maturity of a newer module is not the maturity of the parasitology or cytology products that made the company its name.

Pricing, plan by plan

Annalise.ai

On request
  • Annalise Enterprise$undefined/year
    • Priced per study analysed or as an annual volume subscription
    • CXR and CTB licensed separately
    • Cleared finding set differs by market, which changes what you are buying

Techcyte

On request
  • Techcyte$undefined/year
    • Priced per slide or per annual specimen volume by discipline
    • Each discipline module licensed separately
    • Slide scanning hardware bought separately, not included

Which should you pick?

Choose Annalise.ai if

  • You need annalise enterprise cxr.
  • You work on Web, Cloud, On-premise.
  • You also want annalise enterprise ctb.
Annalise.ai review

Choose Techcyte if

  • You need fusion parasitology suite.
  • You also want cervical cytology.
Techcyte review

Questions people ask

Is Annalise.ai or Techcyte better?
Neither clearly leads. Annalise.ai starts at On request and Techcyte at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Annalise.ai or Techcyte?
Annalise.ai starts at On request and Techcyte at On request.
Does Annalise.ai or Techcyte run on more platforms?
Annalise.ai runs on Web, Cloud, On-premise. Techcyte runs on Web.
What is Annalise.ai best used for?
Annalise.ai is most often used for an emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnest, a teleradiology provider covering many small hospitals that needs consistent triage before a human reads, a screening programme in europe where the broader ce marked decision support indication, rather than the narrow united states triage clearance, is what is being deployed, a radiology department building an ai governance programme that wants one vendor covering both chest radiograph and head ct rather than contracting two separate algorithm suppliers. Of those, an emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnest and a teleradiology provider covering many small hospitals that needs consistent triage before a human reads are not what Techcyte is typically brought in for.
What can Annalise.ai do that Techcyte cannot?
Annalise.ai covers Annalise Enterprise CXR, Annalise Enterprise CTB, Triage and notification, Worklist reprioritisation. Techcyte covers Fusion Parasitology Suite, Cervical cytology, Haematology, Urinalysis.

Answered from the vendors’ own pages

Annalise.ai: How many findings are FDA cleared?

Around ten across chest X-ray and head CT, for triage and notification only. The model reports far more findings than that; the rest are not cleared in the United States.

Techcyte: Is Techcyte FDA cleared?

Not uniformly. Several United States offerings, including the Fusion Parasitology Suite, are labelled research use only and not for diagnostic use in the United States. Check the regulatory status of each specific module for your country before purchase.

Annalise.ai: Is the European position different?

Yes. CE marking under the medical device regulation covers a broader decision support indication than the United States triage and notification clearances, so the same software is a different regulatory product depending on where you deploy it.

Techcyte: Can we use it clinically in Europe?

Techcyte solutions are CE marked and clinically deployed across Europe, which is where its regulatory position is strongest. Confirm the current certificate for the specific module.

Annalise.ai: Does it diagnose?

No. In the United States it is a triage and notification device: it flags studies for earlier review, and the radiologist makes the diagnosis.

Techcyte: Does it eliminate the need for a technologist?

No. AI pre screens and prioritises, but a qualified reviewer still releases results. The saving is in review time per slide.

Annalise.ai: Is Annalise.ai becoming Harrison.ai?

The critical care offering is now marketed under the Harrison.ai name. Ask the vendor to name the contracted product explicitly before signing a multi-year deal.

Techcyte: Do we need a specific scanner?

Techcyte works with several scanner vendors, but disciplines such as parasitology and haematology need multi plane imaging that many histology scanners cannot produce, so confirm hardware compatibility early.

Share

Related pages

More on Annalise.ai

More on Techcyte

Keep looking

Other head to heads